- Home
- TOVX vs JXG Comparison
TOVX vs JXG Comparison
Compare TOVX & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- JXG
- Stock Information
- Founded
- TOVX 2001
- JXG N/A
- Country
- TOVX United States
- JXG China
- Employees
- TOVX N/A
- JXG N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- JXG
- Sector
- TOVX Health Care
- JXG
- Exchange
- TOVX Nasdaq
- JXG Nasdaq
- Market Cap
- TOVX 4.5M
- JXG 4.6M
- IPO Year
- TOVX 2006
- JXG N/A
- Fundamental
- Price
- TOVX $0.42
- JXG $1.02
- Analyst Decision
- TOVX Hold
- JXG
- Analyst Count
- TOVX 1
- JXG 0
- Target Price
- TOVX N/A
- JXG N/A
- AVG Volume (30 Days)
- TOVX 1.2M
- JXG 160.8K
- Earning Date
- TOVX 08-11-2025
- JXG 05-15-2025
- Dividend Yield
- TOVX N/A
- JXG N/A
- EPS Growth
- TOVX N/A
- JXG N/A
- EPS
- TOVX N/A
- JXG 0.86
- Revenue
- TOVX N/A
- JXG $49,840,288.00
- Revenue This Year
- TOVX N/A
- JXG N/A
- Revenue Next Year
- TOVX N/A
- JXG N/A
- P/E Ratio
- TOVX N/A
- JXG $1.23
- Revenue Growth
- TOVX N/A
- JXG 56.53
- 52 Week Low
- TOVX $0.37
- JXG $0.55
- 52 Week High
- TOVX $7.15
- JXG $8.40
- Technical
- Relative Strength Index (RSI)
- TOVX 44.90
- JXG 42.32
- Support Level
- TOVX $0.45
- JXG $0.97
- Resistance Level
- TOVX $0.47
- JXG $1.10
- Average True Range (ATR)
- TOVX 0.04
- JXG 0.10
- MACD
- TOVX 0.00
- JXG 0.03
- Stochastic Oscillator
- TOVX 31.76
- JXG 72.41
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.